Statement of Larry Corey, MD on the Success of the CAPRISA 004 Microbicide Trial

Printable version

The HIV Vaccine Trials Network (HVTN) issued a statement on the CAPRISA 004 microbicide trial. The full statement is below.

Attachment	Size
Corey 20 July.pdf	59.85 KB

Follow Us:

Global HIV Vaccine Enterprise, 200 Park Ave. S. Suite 1501, New York, NY 10003 | +1 212-461-3692 or toll free at +1-866-966-4483

All Content ©2005 - 2010 Global HIV Vaccine Enterprise | Terms of Use | Privacy Policy | Log In / My Account